Bristol-Myers Squibb Company
BMY
$60.66
$0.360.60%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.61% | 68.02% | -46.66% | 3,311.11% | -94.05% |
| Total Depreciation and Amortization | -2.48% | 6.06% | -2.27% | -45.21% | -30.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30,240.00% | -99.69% | 350.00% | -71.34% | 4,182.76% |
| Change in Net Operating Assets | -154.14% | 20,266.67% | 100.80% | -246.63% | -25.25% |
| Cash from Operations | -68.72% | 61.12% | 100.46% | -55.98% | -20.60% |
| Capital Expenditure | -15.63% | 11.36% | -38.85% | 31.22% | -16.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 8.91% | -557.54% | -265.38% | -65.96% | 86.49% |
| Divestitures | 0.00% | 3.33% | 11.11% | -27.03% | 30.59% |
| Other Investing Activities | 59.62% | 319.59% | 75.99% | -288.46% | -152.53% |
| Cash from Investing | 14.34% | -259.83% | 5.21% | -154.59% | 10.50% |
| Total Debt Issued | 106,580.00% | -91.38% | -84.24% | 190.86% | -526.32% |
| Total Debt Repaid | -4,296.51% | 64.39% | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.08% | -0.08% | -0.32% | -3.28% | -0.16% |
| Other Financing Activities | -1,000.00% | -127.27% | 110.68% | -442.11% | -218.75% |
| Cash from Financing | -304.63% | 18.85% | -84.89% | 39.52% | 57.37% |
| Foreign Exchange rate Adjustments | 225.00% | -103.13% | 93.94% | 144.90% | -290.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -276.82% | 79.44% | 228.79% | -78.48% | 53.66% |